publication venue for
- Exposure-response relationship of ramucirumab in RANGE, a randomized phase III trial in advanced urothelial carcinoma refractory to platinum therapy.. 88. 2022
- Spotlight commentary: A role for real-world evidence to inform the clinical care of patients with diabetes mellitus. 2021
- Clinical outcomes of high-intensity doses of atorvastatin in patients with acute coronary syndrome: A retrospective cohort study using real-world data.. 87. 2020
- Prognostic significance of α- and β2-adrenoceptor gene expression in breast cancer patients.. 85. 2019
- Proton pump inhibitors do not impair the effectiveness of metformin in patients with diabetes.. 79. 2015
- Population pharmacokinetic analysis of sorafenib in patients with solid tumours.. 72. 2011
- In vitro and in vivo oxidative metabolism and glucuronidation of anastrozole.. 70. 2010
- Population pharmacokinetics of imatinib mesylate in patients with chronic-phase chronic myeloid leukaemia: results of a phase III study.. 60. 2005
- Population pharmacokinetics of antifibroblast activation protein monoclonal antibody F19 in cancer patients.. 51. 2001
- Phenylbutazone-warfarin interaction in man: further stereochemical and metabolic considerations.. 16. 1983
- Haemodynamic and metabolic effects of dazoxiben at rest and during atrial pacing.. 15 Suppl 1. 1983
- Benzodiazepines in the treatment of depressive, borderline personality, and schizophrenic disorders.. 11 Suppl 1. 1981
- Paroxetine use during pregnancy and the risk of cardiac defects. 2016
- No population left behind: Improving paediatric drug safety using informatics and systems biology. 2020
- Antiresorptive agents' bone-protective and adjuvant effects in postmenopausal women with early breast cancer. 2019
- N-of-1 trials to facilitate evidence-based deprescribing: Rationale and case study. 2022
- The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis. 2016